ing the preterm birth syndrome. American
Journal of Obstretics & Gynecology, 108112. doi: 10.1016/j.ajog.2011.10.864
CATT Research Group, The. (2011). Ranibizumab and Bevacizumab for Neovascular Age
-Related Macular Degeneration. New England Journal of Medicine, 364, 1897-1908.
doi: 10.1056/NEJMoa1102673
Chen, J., & Smith, L. E. (2007). Retinopathy of
Prematurity. Angiogenesis, 10(2), 133-140.
doi: 10.1007/s10456-007-9066-0
Clarkson, J. G., Flynn, J. T., Frazier-Byrne, S., &
Jacobson, S. G. (1989). Evaluation of eyes
with stage-5 retinopathy of prematurity.
Graefe's Archive for Clinical and Experimental Opthamology, 227, 332-334. doi:
10.1007/BF02169407
Corn, A. L., & Erin, J. N. (Eds.). (2010). Foundations of Low Vision: Clinical and Functional
Perspectives, Second Edition. New York,
NY: AFB Press.
Hamilton, B. E., Martin, J. A., & Ventura, S. J.
(2011). Births: Preliminary Data for 2010.
National Vital Statistics Reports, 60(2), 1-6.
Retrieved from http://www.cdc.gov/nchs/
data/nvsr/nvsr60/nvsr60_02.pdf
Shastry, B. S. (2010). Genetic susceptibility to advanced retinopathy of prematurity (ROP).
Journal of Biomedical Science, 17(69). doi:
10.1186/1423-0127-17-69
Vanderbilt Children's Hospital. (2009). Surgeries
and Procedures: Retinopathy of Prematurity. Retrieved November 25, 2012, from
Monroe Carell Jr. Children's Hospital at
Vanderbilt: http://
www.childrenshospital.vanderbilt.org/library/
article.php?article_set=72011
49
